Stay updated with breaking news from Hari Pujar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quick read: Experts at the PDA Annual Meeting highlighted the ways that existing packaging plays a role in containing the products of the future.
Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center. > Atara Biotherapeutics ushered Amie Krause into the role of senior vice president and chief people officer Apri...
Dive Brief: David Davidson, a longtime top executive at gene therapy developer Bluebird bio, will join the richly funded biotech startup Tessera Therapeutics as its chief medical and development officer, the latter company announced Wednesday. At Tessera, Davidson will be joined by former Spark Therapeutics and Moderna executive Hari Pujar, who will become chief operating officer, and by Lin Guey, most recently a vice president at Xilio Therapeutics who has been appointed head of rare disease strategy and operations. Launched by Flagship Pioneering last year, Tessera in January raised $23...